Mechanisms of antimicrobial resistance among hospital-associated pathogens
dc.contributor.author | Khan, Ayesha | |
dc.contributor.author | Miller, William R. | |
dc.contributor.author | Arias, Cesar A. | |
dc.date.accessioned | 2020-05-18T09:44:41Z | |
dc.date.available | 2020-05-18T09:44:41Z | |
dc.date.issued | 2018 | |
dc.description.abstractenglish | Introduction: The introduction of antibiotics revolutionized medicine in the 20th-century permitting the treatment of once incurable infections. Widespread use of antibiotics, however, has led to the development of resistant organisms, particularly in the healthcare setting. Today, the clinician is often faced with pathogens carrying a cadre of resistance determinants that severely limit therapeutic options. The genetic plasticity of microbes allows them to adapt to stressors via genetic mutations, acquisition or sharing of genetic material and modulation of genetic expression leading to resistance to virtually any antimicrobial used in clinical practice. Areas covered: This is a comprehensive review that outlines major mechanisms of resistance in the most common hospital-associated pathogens including bacteria and fungi. Expert commentary: Understanding the genetic and biochemical mechanisms of such antimicrobial adaptation is crucial to tackling the rapid spread of resistance, can expose unconventional therapeutic targets to combat multidrug resistant pathogens and lead to more accurate prediction of antimicrobial susceptibility using rapid molecular diagnostics. Clinicians making treatment decisions based on the molecular basis of resistance may design therapeutic strategies that include de-escalation of broad spectrum antimicrobial usage, more focused therapies or combination therapies. These strategies are likely to improve patient outcomes and decrease the risk of resistance in hospital settings. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1080/14787210.2018.1456919 | |
dc.identifier.issn | 1744-8336 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12495/2929 | |
dc.language.iso | eng | |
dc.publisher | Taylor and Francis | spa |
dc.publisher.journal | Expert Review of Anti-infective Therapy | spa |
dc.relation.ispartofseries | Expert Review of Anti-infective Therapy, 1744-8336, Vol 16, Num 4, 2018, pag 269-287 | spa |
dc.relation.uri | https://www.tandfonline.com/doi/abs/10.1080/14787210.2018.1456919?journalCode=ierz20 | |
dc.rights.creativecommons | 2018 | |
dc.rights.local | Acceso cerrado | spa |
dc.subject.armarc | Farmacorresistencia microbiana | spa |
dc.subject.armarc | Infección hospitalaria | spa |
dc.subject.armarc | Enfermedad iatrogénica | spa |
dc.subject.keywords | Antibiotic resistance | spa |
dc.subject.keywords | Antimicrobial resistance | spa |
dc.subject.keywords | Nosocomial pathogens | spa |
dc.subject.keywords | Hospital-acquired infections | spa |
dc.subject.keywords | Hospital-associated pathogens | spa |
dc.subject.keywords | Mechanisms of resistance | spa |
dc.title | Mechanisms of antimicrobial resistance among hospital-associated pathogens | spa |
dc.title.translated | Mechanisms of antimicrobial resistance among hospital-associated pathogens | spa |
dc.type | article | spa |
dc.type.hasversion | info:eu-repo/semantics/publishedVersion | |
dc.type.local | artículo | spa |
Archivos
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: